FDA.reportPublic FDA data

capsaicin 0.375 MG/ML / menthol 100 MG/ML / methyl salicylate 300 MG/ML Topical Lotion [Dendracin Neurodendraxcin]

RxCUI
1116976
RxNorm name
capsaicin 0.375 MG/ML / menthol 100 MG/ML / methyl salicylate 300 MG/ML Topical Lotion [Dendracin Neurodendraxcin]
Display name
DENDRACIN NEURODENDRAXCIN (Topical)
Full name
capsaicin 0.375 MG/ML / menthol 100 MG/ML / methyl salicylate 300 MG/ML Topical Lotion [Dendracin Neurodendraxcin]
Term type
SBD
Status
Active
Strength
0.0375-10-30%
Dose form
Lotion
Route
Topical
Updated
2026-07-18 06:59:26

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
092011
Active start
092011
Multiple ingredient
YES
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
capsaicin0.375 MG / 1 MLcapsaicincapsaicin
methyl salicylate300 MG / 1 MLmethyl salicylatemethyl salicylate
menthol100 MG / 1 MLmentholmenthol

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Topical Lotion316983

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
capsaicin1992
methyl salicylate29787
menthol6750

Source Vocabulary Codes#

Code type, Value, Category table
Code typeValueCategory
PRESCRIBABLEYATTRIBUTES
RXNAV_STRDendracin Neurodendraxcin (capsaicin 0.0375 % / menthol 10 % / methyl salicylate 30 % ) Topical LotionNAMES
RxNorm Namecapsaicin 0.375 MG/ML / menthol 100 MG/ML / methyl salicylate 300 MG/ML Topical Lotion [Dendracin Neurodendraxcin]NAMES
RxNorm SynonymDendracin Neurodendraxcin (capsaicin 0.0375 % / menthol 10 % / methyl salicylate 30 % ) Topical LotionNAMES
TTYSBDATTRIBUTES
RxCUI1116976CODES
MMSL_CODEBD27842CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 11 matching rows.

NDC11, Source, Active table
NDC11SourceActive
27495000602rxnav_ndcsyes
27495000604rxnav_ndcsyes
45865038060rxnav_ndcsyes
45865038151rxnav_ndcsyes
63629396601rxnav_ndcsyes
35356061202rxnav_historical
35356061204rxnav_historical
50436016501rxnav_historical
52959093060rxnav_historical_indirect
58118100606rxnav_historical
63629379301rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
b36c7977-557d-4ab4-bc4a-35875f1848e6Dendracin Neurodendraxcin®, Topical Pain Relief LotionUnit Dose Services20180702
942cfced-cfab-4c25-a425-e15cbf0d09aeNational Council for Prescription Drug Programs20120724
be4481ce-4c12-4c8b-989c-abf979f115b6National Council for Prescription Drug Programs20120724
c81cd324-7a97-49d7-81e5-2e41b031af68National Council for Prescription Drug Programs20120724
ca50ce2a-f680-4912-8e86-d77176871f30National Council for Prescription Drug Programs20120724
d36e4299-fb03-4062-97ce-e9e04cf18587Dendracin Neurodendraxcin®, Topical Pain Relief LotionH.J. Harkins Company, Inc. | Physicians Science & Nature Inc. | Westwood Laboratories20111207

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCM02ABCapsaicin and similar agentsATC1-4capsaicin
ATCN01BXOther local anestheticsATC1-4capsaicin
MEDRTD002211CapsaicinCHEMhas_ingredientcapsaicin
MEDRTD008610MentholCHEMhas_ingredientmenthol
MEDRTD012459SalicylatesCHEMhas_ingredientmethyl salicylate
MEDRTD059787Acute PainDISEASEmay_treatmethyl salicylate
MEDRTD001168ArthritisDISEASEmay_treatmethyl salicylate
MEDRTD001416Back PainDISEASEmay_treatmethyl salicylate
MEDRTD003288ContusionsDISEASEmay_treatmethyl salicylate
MEDRTD003929Diabetic NeuropathiesDISEASEmay_treatcapsaicin
MEDRTD004342Drug HypersensitivityDISEASEci_withcapsaicin
MEDRTD004342Drug HypersensitivityDISEASEci_withmenthol
MEDRTD004342Drug HypersensitivityDISEASEci_withmethyl salicylate
MEDRTD006562Herpes ZosterDISEASEmay_treatcapsaicin
MEDRTD007249InflammationDISEASEmay_treatmethyl salicylate
MEDRTD009120Muscle CrampDISEASEmay_treatmethyl salicylate
MEDRTD009437NeuralgiaDISEASEmay_treatcapsaicin
MEDRTD010146PainDISEASEmay_preventcapsaicin
MEDRTD010146PainDISEASEmay_treatmenthol
MEDRTD012871Skin DiseasesDISEASEmay_treatmenthol
MEDRTD013180Sprains and StrainsDISEASEmay_treatmethyl salicylate
MEDRTN0000000069Calcium Channel AntagonistsMOAhas_moamenthol
MEDRTN0000000160Cyclooxygenase InhibitorsMOAhas_moamethyl salicylate
MEDRTN0000000105Neurotransmitter Transporter InteractionsMOAhas_moacapsaicin
MEDRTN0000000108Prostaglandin Receptor AntagonistsMOAhas_moamethyl salicylate
MEDRTN0000008836Decreased Prostaglandin ProductionPEhas_pemethyl salicylate
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_pecapsaicin
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_pementhol
MEDRTN0000009006Decreased Thromboxane ProductionPEhas_pemethyl salicylate

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH0.375 MG/ML / 100 MG/ML / 300 MG/ML
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESPRESCRIBABLEY
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESTTYSBD
CODESMMSL_CODEBD27842
CODESRxCUI1116976
NAMESPrescribable SynonymDENDRACIN Neurodendraxcin 0.0375 % / 10 % / 30 % Topical Lotion
NAMESRXNAV_STRDendracin Neurodendraxcin (capsaicin 0.0375 % / menthol 10 % / methyl salicylate 30 % ) Topical Lotion
NAMESRxNorm Namecapsaicin 0.375 MG/ML / menthol 100 MG/ML / methyl salicylate 300 MG/ML Topical Lotion [Dendracin Neurodendraxcin]
NAMESRxNorm SynonymDendracin Neurodendraxcin (capsaicin 0.0375 % / menthol 10 % / methyl salicylate 30 % ) Topical Lotion
SOURCESSourceMicromedex RED BOOK